News Briefs: Professional Development Opportunities

This roundup includes the following professional development opportunities briefs:

Physician-learners can receive up-to-date information and acquire new skills at two upcoming live AAFP CME courses.

"Infant, Child and Adolescent Medicine" will be held July 18-20 in Cambridge, Mass.

Course attendees can expect to learn about the latest clinical recommendations, emerging disease trends and treatment methods. Topics will range from neonatal problems to well-child exams to drug abuse in adolescents.

Specifically, course faulty will teach physician-learners how to integrate preventive care into the spectrum of office practice by using established guidelines to deal with developmental issues, acute illness, chronic illness and behavioral disorders in the framework of a medical home.

This activity, which is presented in cooperation with the Society for Adolescent Medicine, has been reviewed and is acceptable for 23 or more Prescribed credits.

"Essentials of Musculoskeletal Care" will be held Aug. 13-15 in Orlando, Fla. Attendees can learn about the most common musculoskeletal issues FPs see in their offices via didactic lectures, small-group sessions and hands-on workshops.

Among specific topics to be addressed are

This activity has been reviewed and is acceptable for 17.25 or more Prescribed credits.

The FDA and the CDC have developed an online course designed to introduce public health officials, emergency managers and Strategic National Stockpile coordinators to the federal government's Emergency Use Authorization, or EUA, and provide a basic understanding of the current policies and procedures governing the EUA process.

An EUA allows the use of drugs, biologics and medical devices that are not FDA-approved, licensed or cleared to diagnose, treat or prevent a serious or life-threatening disease or condition in an emergency when there are no adequate, approved alternatives. Products subject to an EUA either have not been approved by the FDA or might be approved for another use.

The course summarizes the steps that HHS and the FDA must take for an EUA to be issued and identifies the conditions for using unapproved medical products under an EUA.